Johnson & Johnson Comprehensive Income 2010-2024 | JNJ

Johnson & Johnson comprehensive income for the quarter ending December 31, 2024 was $-11.741B, a 6.27% decline year-over-year.

  • Johnson & Johnson comprehensive income for 2024 was $-11.741B, a 6.27% decline from 2023.
  • Johnson & Johnson comprehensive income for 2023 was $-12.527B, a 3.39% decline from 2022.
  • Johnson & Johnson comprehensive income for 2022 was $-12.967B, a 0.7% decline from 2021.

Johnson & Johnson Comprehensive Income 2010-2024 | JNJ

  • Johnson & Johnson comprehensive income for 2024 was $-11.741B, a 6.27% decline from 2023.
  • Johnson & Johnson comprehensive income for 2023 was $-12.527B, a 3.39% decline from 2022.
  • Johnson & Johnson comprehensive income for 2022 was $-12.967B, a 0.7% decline from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$827.9B
Novo Nordisk (NVO)$375.8B
AbbVie (ABBV)$354.6B
Roche Holding AG (RHHBY)$262.5B
Merck (MRK)$221.8B
Novartis AG (NVS)$219.3B
Pfizer (PFE)$146.8B
Sanofi (SNY)$137.4B
Bayer (BAYRY)$22.6B
Innoviva (INVA)$1.1B